eighteen patients are described in whom initially sensitive microorganisms were replaced by resistant isolates during administration of ceftriaxone ( n = 8 ) , cefoperazone ( n = 5 ) , moxalactam ( n = 4 ) , cefotaxime ( n = 2 ) or ceftazidime ( n = 1 ) , despite combination with aminoglycosides .
C0007561
ceftriaxone
C0007554
cefotaxime